Ventricular long-axis function is of major importance for long-term survival in patients with heart failure

B Grüner Sveälv1, E L Olofsson, B Andersson

  • 1Department of Molecular and Clinical Medicine/Cardiology, Wallenberg Laboratory, Sahlgrenska Academy at Göteborg University, Sweden.

Insights

Left ventricular long-axis systolic amplitude is a crucial predictor of long-term survival in heart failure patients, independent of other clinical factors. This finding highlights the importance of basal ventricular function for patient outcomes.

Area of Science:

  • Cardiology
  • Echocardiography
  • Heart Failure Research

Background:

  • Heart failure significantly impacts long-term survival.
  • Assessing ventricular function is key to predicting outcomes.
  • Traditional assessments often focus on short-axis function.

Purpose of the Study:

  • To evaluate the predictive value of left ventricular (LV) long-axis (LAX) systolic and diastolic function compared to short-axis (SAX) function for long-term survival in heart failure patients.
  • To determine if LAX function is an independent predictor of survival.

Main Methods:

  • Prospective epidemiological study involving 228 heart failure patients (mean age <65 years, ejection fraction 44%).
  • Echocardiography was used to assess both SAX and LAX function of the right and left ventricles.
  • Patients were followed for 10 years for survival or heart transplantation.

Main Results:

  • LV LAX systolic amplitude strongly predicted long-term survival (p<0.001).
  • In multivariate analysis, LV LAX systolic amplitude was the sole independent predictor of outcome (HR 0.89, p=0.02), even after adjusting for clinical variables and SAX function.
  • Survival curves stratified by LAX systolic amplitude quartiles showed clear differentiation in outcomes.

Conclusions:

  • LV LAX systolic amplitude independently predicts survival in heart failure patients.
  • These findings underscore the significance of basal ventricular segments for overall ventricular function and long-term prognosis.
  • LAX function provides crucial prognostic information beyond SAX measures.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...